Comprehensive Guide to Fetal Heart Rate Analysis and Oxygenation and Monitoring

Fetal Oxygenation and Circulation

  • Fetal Oxygenation Pathway:

    • The process begins when the mother breathes in oxygenated blood.

    • Oxygenated blood travels from the maternal system to the uterus through the maternal vasculature.

    • The oxygenated blood passes through the placenta.

    • The blood then travels up the umbilical cord through the umbilical vein to reach the fetus.

    • Fetal circulation distributes this oxygenated blood throughout the fetal body.

    • Deoxygenated blood and waste products from the fetus are returned to the placenta via the umbilical arteries.

    • The placenta facilitates the gas exchange process with the maternal blood.

    • The entire cycle repeats continuously.

  • Umbilical Cord Structure:

    • Wharton's Jelly: This is a jelly-like substance designed to protect the umbilical vein and the two umbilical arteries from compression, ensuring blood flow is not interrupted.

    • Umbilical Vein: There is one umbilical vein, and its function is to carry oxygenated blood from the placenta to the fetus.

    • Umbilical Arteries: There are two umbilical arteries, which carry deoxygenated blood and fetal waste products from the fetus back to the placenta.

  • Fetal Circulation Adaptations (Shunts):

    • Ductus Venosus: This shunt allows oxygenated blood to bypass the fetal liver and flow directly into the inferior vena cava.

    • Foramen Ovale: This is a connection between the right atrium and the left atrium, allowing blood to bypass the fluid-filled lungs.

    • Ductus Arteriosus: This connects the pulmonary artery to the aorta, further facilitating the bypass of the fetal lungs.

  • Key Principle of Fetal Exchange: There is no mixing of maternal and fetal blood. The exchange of gases, transfer of nutrients, and removal of waste products occur solely through the process of diffusion within the intervillous space of the placenta.

Fetal Monitoring Methods

  • Intermittent Fetal Heart Rate Monitoring:

    • Fetoscope: An older, traditional method that is rarely utilized in modern clinical settings.

    • Doppler: Provides the fetal heart rate but does not offer information regarding oxygenation status.

    • Major Limitation: Intermittent methods only provide a numerical heart rate and cannot assess the ongoing oxygenation status of the fetus.

  • Continuous Electronic Fetal Monitoring (EFM):

    • External Monitoring:

      • Ultrasound Transducer: This is placed over the fetal back to detect and record the fetal heart rate.

      • Toco-transducer (Toco): This device is placed over the uterine fundus. It uses pressure sensors to detect uterine contractions, which are represented as "hills" on the monitor tracing. Maternal pushing can cause sharp spikes on this reading. The Toco is non-invasive.

    • Internal Monitoring:

      • Fetal Scalp Electrode (FSE) or Spiral Electrode: This is a small coiled clip attached directly to the fetal presenting part (usually the head).

      • Criteria for FSE Use:

        • Membranes must be ruptured.

        • The cervix must be dilated to at least 2cm2\,cm (though 1cm1\,cm may be possible with highly experienced assistance).

        • The presenting part must be the head and must be low enough for the practitioner to reach.

        • Placement must be performed by a skilled practitioner with at least one year of Labor and Delivery (L&D) experience.

        • Crucial Rule: The electrode must be placed on a bony part of the head (sutures), never on a soft spot (fontanelle).

      • Advantages: Internal monitoring provides a more accurate and continuous tracing, particularly in cases where external monitoring is difficult or inconsistent.

  • Equipment and Systems:

    • Monitors display the fetal heart rate and contraction patterns on a screen or paper strip.

    • Central Monitoring Systems: These allow for remote viewing of fetal heart rate tracings from a central nursing station.

    • Paper strips are used as a backup if central systems fail or during power outages.

Fetal Auscultation and Position

  • Placement Logic: The fetal heart rate is best heard through the fetal back.

  • Cephalic Presentation (Head Down): The fetal heart rate is most audible in the lower quadrants of the maternal abdomen.

  • Breech Presentation (Buttocks Down): The fetal heart rate is most audible in the upper quadrants of the maternal abdomen.

  • Leopold's Maneuvers: These maneuvers are performed by the clinician to determine the fetal position, which subsequently guides the correct placement of monitoring devices.

Interpreting Fetal Heart Rate Tracings

  • Baseline Fetal Heart Rate (FHR):

    • Definition: The average FHR observed over a 10-minute10\text{-minute} window, excluding accelerations, decelerations, and periods of marked variability.

    • Normal Baseline Range: Between 110 to 160bpm110\text{ to } 160\,bpm.

    • Establishment Criteria: Requires at least 10minutes10\,minutes of tracing data. The baseline is determined using at least 2minutes2\,minutes of "flat" tracing (not necessarily consecutive) within that 10-minute10\text{-minute} window.

    • Tachycardia: A baseline FHR greater than 160bpm160\,bpm.

    • Bradycardia: A baseline FHR less than 110bpm110\,bpm.

  • Variability:

    • Definition: Irregular fluctuations in the FHR from beat to beat.

    • Significance: This is the single most important indicator of fetal well-being and oxygenation status. It reflects the constant interplay between the sympathetic nervous system (which increases heart rate) and the parasympathetic nervous system (which decreases heart rate), indicating an intact brainstem.

    • Types of Variability:

      • Absent Variability: Undetectable fluctuations, appearing as a completely flat line on the monitor. This is an ominous sign of lack of oxygenation and potential fetal injury.

      • Minimal Variability: Fluctuations of < 5\,bpm. Possible causes include maternal pain medication, magnesium sulfate administration, or fetal sleep cycles. This requires close observation.

      • Moderate Variability: Fluctuations ranging from 6 to 25bpm6\text{ to } 25\,bpm. This is the reassuring and desired level, indicating a healthy, well-oxygenated fetus.

      • Marked Variability: Fluctuations > 25\,bpm. This can be caused by fetal stimulation or excitement. If sustained, it may be a precursor to fetal distress.

    • Fetal Sleep Cycles: Variability may naturally decrease during these cycles, but absent variability is never considered normal.

    • Nervous System Maturity: The parasympathetic nervous system is not fully functional until approximately 2828 weeks of gestation. Therefore, variability assessment is less reliable in preterm infants younger than 2828 weeks.

Periodic and Episodic Changes

  • Accelerations (A's):

    • Definition: Abrupt increases in the FHR above the established baseline.

    • Criteria for 32\ge 32 Weeks Gestation: An increase of 15bpm\ge 15\,bpm above baseline lasting for 15seconds\ge 15\,seconds (known as the 15×1515 \times 15 rule).

    • Criteria for 28-31 Weeks Gestation: An increase of 10bpm\ge 10\,bpm above baseline lasting for 10seconds\ge 10\,seconds (known as the 10×1010 \times 10 rule).

    • Significance: A highly reassuring sign indicating adequate oxygenation and an intact fetal nervous system.

  • Decelerations (D's):

    • Definition: Periodic or episodic decreases in FHR below the baseline.

    • Periodic Changes: Occur in association with uterine contractions.

    • Episodic Changes: Occur independently of uterine contractions.

    • Types of Decelerations:

      1. Early Decelerations:

        • Cause: Fetal head compression as the fetus descends into the birth canal.

        • Appearance: A gradual decrease that mirrors the contraction (U-shaped). The onset, nadir (lowest point), and recovery match the start, peak, and end of the contraction.

        • Significance: Benign and not ominous.

      2. Late Decelerations:

        • Cause: Placental insufficiency, resulting in reduced oxygen supply to the fetus.

        • Appearance: A gradual decrease (U-shaped) where the onset begins after the peak of the contraction, and the recovery to baseline occurs only after the contraction has finished. There is a visible "lag."

        • Significance: Ominous sign of fetal hypoxia; requires immediate intervention.

      3. Variable Decelerations:

        • Cause: Umbilical cord compression.

        • Appearance: Abrupt onset (drop of 15bpm\ge 15\,bpm within < 30\,seconds), lasting 15seconds\ge 15\,seconds but < 2\,minutes. These are often V-shaped or W-shaped and their timing relative to contractions is inconsistent.

        • "Shoulders": Small accelerations immediately preceding or following the deceleration, caused by compensatory mechanisms responding to blood pressure changes from cord compression.

        • Significance: Concerning if they are recurrent, deep, or prolonged.

      4. Prolonged Deceleration:

        • Definition: A deceleration lasting longer than 2minutes2\,minutes but less than 10minutes10\,minutes.

        • Note: If a deceleration lasts longer than 10minutes10\,minutes, it is classified as a baseline change.

        • Significance: Non-reassuring; indicates potential fetal compromise.

Other FHR Patterns and Contraction Interpretation

  • Sinusoidal Pattern:

    • Appearance: A smooth, regular, wave-like pattern resembling a sine wave in frequency and amplitude.

    • Causes: Severe fetal anemia, cardiac anomalies, or iatrogenic effects (e.g., narcotic medication, fetal scalp stimulation).

    • Significance: Severe compromise; usually mandates immediate delivery.

    • Pseudo-Sinusoidal Pattern: Less smooth and regular than a true sinusoidal pattern; can be caused by thumb-sucking or maternal narcotics.

  • Contraction Interpretation:

    • Frequency: Measured from the start of one contraction to the start of the next.

    • Duration: The length of time a single contraction lasts.

    • Intensity: Measured via palpation (mild, moderate, strong) or an Intrauterine Pressure Catheter (IUPC) in mmHgmmHg. External Toco-transducers cannot accurately measure intensity.

    • Resting Tone: The period of uterine relaxation between contractions. It should be soft on palpation; IUPC measures it as baseline pressure.

  • Tachysystole:

    • Criteria: More than 55 contractions in a 10-minute10\text{-minute} period, averaged over a 30-minute30\text{-minute} window.

    • Management Steps:

      1. Decrease or discontinue oxytocin (Pitocin) infusion.

      2. Administer an IV fluid bolus (5001000mL500-1000\,mL normal saline).

      3. Turn the patient to a lateral (side) position.

      4. Notify the healthcare provider.

      5. Consider tocolytic medications if previous steps fail and FHR remains non-reassuring.

Reassuring vs. Non-Reassuring Tracings

  • Reassuring Fetal Heart Rate Tracing:

    • Normal baseline (110 to 160bpm110\text{ to } 160\,bpm).

    • Moderate variability.

    • Absence of significant decelerations.

    • Accelerations may or may not be present.

    • Early decelerations may be present.

  • Non-Reassuring Fetal Heart Rate Tracing:

    • Recurrent late decelerations.

    • Recurrent variable decelerations.

    • Minimal or absent variability.

    • Bradycardia (< 110\,bpm).

    • Prolonged decelerations (> 2\,minutes).

    • Sinusoidal pattern.

  • Reactive Non-Stress Test (NST):

    • Requires two accelerations (meeting gestational criteria) within a 20-minute20\text{-minute} period.

  • Recurrent Decelerations: Defined as occurring with more than 50%50\% of contractions in a specified time frame (e.g., 30minutes30\,minutes).

Intrauterine Resuscitation (IUR)

  • Goal: To maximize fetal oxygenation and uterine blood flow.

  • Priority Actions (In Specific Order):

    1. Reposition the Patient: Move the patient to their side (preferably left lateral). Avoid the supine position to prevent vena cava compression.

    2. Administer IV Fluid Bolus: Increase volume with 5001000mL500-1000\,mL normal saline (use caution with preeclamptic patients).

    3. Discontinue Oxytocin (Pitocin): Stop any induction/augmentation agents.

    4. Administer Oxygen: Provide 10L/min10\,L/min via a non-rebreather mask.

    5. Consider Tocolytics: Use if tachysystole persists and the tracing is non-reassuring.

    6. Modify Pushing Efforts: In the second stage of labor, push every other contraction or on the side.

Additional Assessments and Mnemonics

  • Fetal Scalp Stimulation:

    • Procedure: A gentle rubbing of the fetal scalp during a vaginal exam.

    • Response: An acceleration in the FHR is expected and is a reassuring sign suggesting the absence of fetal acidosis.

  • Umbilical Cord Gas Analysis:

    • Performs at birth to assess oxygenation and acid-base status.

    • Arterial Sample: Reflects the fetal acid-base status. Normal pH7.20pH \ge 7.20. Low pH suggests acidosis; elevated PCO2PCO_2 or negative base deficit suggests distress.

    • Venous Sample: Reflects placental function; used for comparison.

  • V-CHOPS Mnemonic:

    • Variable Decelerations \rightarrow Cord Compression

    • Early Decelerations \rightarrow Head Compression

    • Accelerations \rightarrow Okay (Normal Oxygenation)

    • Late Decelerations \rightarrow Placental Insufficiency

Interpretation Methodology and Practice

  • Systematic Approach:

    1. Establish Baseline FHR (10min10\,min average, 2min2\,min flat data).

    2. Assess Variability (Absent, Minimal, Moderate, Marked).

    3. Identify Periodic/Episodic Changes (Accelerations/Decelerations).

    4. Evaluate Uterine Contractions (Frequency, Duration, Intensity).

    5. Check Resting Tone.

  • Practice Problem 1:

    • Data: Baseline 135bpm135\,bpm, moderate variability, occasional accelerations.

    • Interpretation: Reassuring tracing. Intervention: Continue routine monitoring.

  • Practice Problem 2:

    • Data: Recurrent late decelerations after receiving oxytocin.

    • Cause: Placental insufficiency (likely due to tachysystole from oxytocin).

    • Priority Action: Reposition the patient to a lateral position first, then follow IUR protocols (stop oxytocin, bolus, oxygen).